)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Icade
Icade (ICAD) investor relations material
Icade Q3 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 TU earnings summary21 Oct, 2026
Executive summary
9M 2026 consolidated revenue was €887.1m, down 3.9% YoY; FY 2026 NCCF guidance remained €2.90–€3.10 per share.
Portuguese healthcare disposals generated ~€115m net proceeds, while an 81.5% controlling interest in Comet was acquired for ~€40m.
Financial highlights
9M Property Investment rental income was €250.0m, down 5.0% reported and 0.9% like-for-like.
Property Development IFRS revenue was €622.2m, down 4.4%; economic revenue was €696.4m, also down 4.4%.
Residential development revenue was €639.9m, up 1.0%; commercial revenue fell 40.2% to €52.7m after prior-year project completions and no new sales.
Comet contributed nearly €5m of revenue; 9M other revenue was €15m versus €9m a year earlier.
Outlook and guidance
FY 2026 NCCF guidance unchanged at €2.90–€3.10 per share: €2.25–€2.45 from strategic operations and ~€0.65 from non-strategic operations.
The €15m cost-reduction plan is complete; selective investment and financial discipline are planned to continue in 2027.
FY 2027 guidance will be announced with FY 2026 results in February 2027; management did not reaffirm 2026 as the strategic cash-flow trough amid uncertainty.
A 2026 dividend equal to distributable profit, with a scrip option, is under consideration for shareholder approval in 2027.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Icade
- Asset disposals, resilient operations, and stable 2026 guidance amid market headwinds.ICAD
Q2 2026 - 2025 results, €1.92/share dividend, and all resolutions—including sustainability—approved.ICADAGM 2026
- €402m asset sale boosts liquidity, but Q1 revenue drops 14.7%; guidance unchanged.ICADQ1 2026 TU
- NCCF was €3.57/share, with strong leasing, disposals, and cost discipline amid value declines.ICADQ4 2025
- €430m in disposals and strong leasing support stable 2025 outlook despite revenue decline.ICADQ3 2025 TU
- Stable revenue and resilient investment offset development impairments; FY 2024 guidance maintained.ICADQ2 2024
- Strong results, strategic progress, and all resolutions approved with high support.ICADAGM 2025
- Revenue up 1.2%, leasing and residential growth support stable outlook for 2025.ICADQ1 2025
- 2024 NCCF beat guidance, but profit and asset values fell; 2025 outlook remains cautious.ICADQ4 2024
Next Icade earnings date
Q4 20269 Feb, 2027
Icade
Next Icade earnings date
Q4 20269 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Icade is a French real estate investment company involved in the development, management, and investment of commercial and healthcare properties. The company operates across several segments, including office real estate, healthcare real estate, and property development, catering to the needs of businesses, healthcare providers, and local communities. Icade's portfolio includes office buildings, business parks, and healthcare facilities across France, with a focus on sustainable development and energy-efficient buildings. The company is headquartered in Paris, France, and its shares are listed on Euronext Paris.